Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.

Source:http://linkedlifedata.com/resource/pubmed/id/17289397

Download in:

View as

General Info

PMID
17289397